World number two and five-time Grand Slam champion Iga Swiatek has accepted a one-month ban after testing positive for a banned substance.
The 23-year-old reigning French Open champion tested positive for the heart drug trimetazidine (TMZ) in an out-of-competition sample in August 2024, when she was world number one.
The International Tennis Integrity Agency (ITIA) confirmed on Thursday that an investigation found the source was a contaminated regulated drug.
It therefore concluded that Swiatek was not responsible for any material fault or negligence in the failed test.
The Polish player was provisionally suspended on September 12 before successfully appealing and missed three tournaments.
Because Swiatek's culpability level is at the lowest end of the scale for “no material fault or negligence,” the ITIA offered a one-month suspension, which she accepted on Wednesday.
Since Swiatek has been provisionally suspended until October 4, an additional eight days of her suspension will remain in effect.
The Pole also had to forgo the prize money for her entry into the semi-finals of the Cincinnati Open, the tournament that immediately followed the test.
